Pfizer has prevailed over Teva Novopharm in its Canadian patent infringement litigation involving a generic version of Viagra (sildenafil). A federal judge has declared that the company has "met its legal burden" in establishing the validity of patent No 2,163,446.
Judge Michael Kelen of the Federal Court of Canada, in a June 18th ruling, prohibited the Canadian minister of health...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?